Department of Chemistry, Shiv Nadar University, Chithera, Dadri, 203207, India.
Future Med Chem. 2012 Oct;4(16):2039-47. doi: 10.4155/fmc.12.128.
Chemical and biological network analysis has recently garnered intense interest from the perspective of drug design and discovery. While graph theoretic concepts have a long history in chemistry - predating quantum mechanics - and graphical measures of chemical structures date back to the 1970s, it is only recently with the advent of public repositories of information and availability of high-throughput assays and computational resources that network analysis of large-scale chemical networks, such as protein-protein interaction networks, has become possible. Drug design and discovery are undergoing a paradigm shift, from the notion of 'one target, one drug' to a much more nuanced view that relies on multiple sources of information: genomic, proteomic, metabolomic and so on. This holistic view of drug design is an incredibly daunting undertaking still very much in its infancy. Here, we focus on current developments in graph- and network-centric approaches in chemical and biological informatics, with particular reference to applications in the fields of SAR modeling and drug design. Key insights from the past suggest a path forward via visualization and fusion of multiple sources of chemical network data.
化学和生物网络分析最近从药物设计和发现的角度引起了强烈的兴趣。虽然图论概念在化学领域有着悠久的历史——甚至早于量子力学——而且化学结构的图形化度量可以追溯到 20 世纪 70 年代,但直到最近,随着信息公共存储库的出现以及高通量测定和计算资源的可用性,才有可能对大规模化学网络(如蛋白质-蛋白质相互作用网络)进行网络分析。药物设计和发现正在经历从“一个靶点,一个药物”的概念向更加微妙的观点的转变,这种观点依赖于多种信息来源:基因组学、蛋白质组学、代谢组学等。这种药物设计的整体观点是一项令人难以置信的艰巨任务,仍处于起步阶段。在这里,我们专注于化学和生物信息学中基于图和网络的方法的最新发展,特别参考了 SAR 建模和药物设计领域的应用。过去的关键见解表明,通过可视化和融合多种化学网络数据可以找到前进的道路。